Current stock page

Financial Data

VOR Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareBiotechnologyScore data as of Nov 13, 2026

VORVor Biopharma Inc.

Healthcare / Biotechnology

Leader

Sector Leader

BullishEdge 10/10
$19.42+$0.10 (+0.52%)

Latest quote

  • Momentum
    72
  • Value
    —
  • Quality
    69
  • Risk resilience
    46
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Nov 16, 2026.

Income statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Revenue$0$0$0$0$0$0$0$0
Gross Profit$0$0-$28K$0$0$0$0-$865K
Operating Income-$58.44M-$47.85M-$35.16M-$35.96M-$28.11M-$274.28M-$33.29M-$31.31M
Net Income-$86.73M-$62.81M-$219.59M$1.72B-$812.68M-$1.57B-$32.49M-$30.71M
EPS-$1.45-$1.16-$5.11$307.53-$121.63-$251.2-$5.2-$9
Cash flow statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Operating Cash Flow-$32.75M-$25.67M-$38.25M-$22.8M-$53.66M-$35.18M-$31.07M-$24.06M
Capital Expenditure-$25K-$120K-$48K-$314K-$244K-$152K-$231K-$72K
Free Cash Flow-$32.77M-$25.79M-$38.29M-$23.12M-$53.91M-$35.34M-$31.3M-$24.14M
Net Cash Provided By Operating Activities-$32.75M-$25.67M-$38.25M-$22.8M-$53.66M-$35.18M-$31.07M-$24.06M
Balance sheet
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Assets$496.31M$481.05M$506.75M$464.13M$176.24M$205.37M$109.31M$142.89M
Total Debt$2.81M$2.88M$2.94M$3M$3.06M$0$30.78M$31.83M
Cash And Cash Equivalents$78.98M$107.86M$169.87M$396.49M$160.46M$192.99M$50.05M$81.95M
Total Liabilities$633.49M$681.25M$657.17M$628.44M$2.4B$1.71B$43.24M$46.23M
Total Stockholders Equity-$137.17M-$200.2M-$150.42M-$164.31M-$2.23B-$1.51B$66.07M$96.66M
Key financial metrics
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio0.882.04——————
P/B ratio——————0.320.61
P/S ratio————————
Debt To Equity——————0.470.33
Free Cash Flow Yield-10.11%-11.02%-22.01%-98.99%-222.07%-54.86%-4.71%-170.64%
Financial ratios
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio0.882.04——————
P/B ratio——————0.320.61
P/S ratio————————
Return On Equity——————-179.50%-120.95%
Debt To Equity——————0.470.33

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
Pe0.06x
Pb-8.45x
EPS Growth Yoy98.81%
Gross Margin0.00%
Operating Margin0.00%
ROE-830.38%
ROIC-38.54%
Debt To Equity-0.02
FCF Yield-11.40%

As of Nov 13, 2026

Technical indicators
MetricValue
Close$19.42
Volume739,311
RSI (14)48.82
MACD-0.01
MACD signal-0.06
MACD histogram0.04
ADX (14)8.88
SMA (50)$19.99
SMA (200)$17.53
ATR (14)$1.23
Historical volatility (annualized)62.06%
Volume (20-day average)717,412

As of Nov 13, 2026

Risk measures
MetricValue
Resilience score46/100
Beta1.7
Annual volatility93.53%
Max Drawdown-33.41%
Sharpe Ratio1.15
VaR (95%, 1-day)-7.95%

As of Nov 13, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

VOR Financial Data FAQ

What is Vor Biopharma Inc.'s revenue?

Vor Biopharma Inc.'s revenue is one of the core financial data points for VOR. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Vor Biopharma Inc.'s revenue growing?

Revenue growth shows whether Vor Biopharma Inc. is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is VOR's EPS?

VOR's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Vor Biopharma Inc.'s net income?

Vor Biopharma Inc.'s net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Vor Biopharma Inc. generate?

Free cash flow shows how much cash Vor Biopharma Inc. generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Vor Biopharma Inc. have?

Cash and debt help frame VOR's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.